PAVM News and Press, PAVmed Inc. From 05/06/21

Four new senior executives will support growth strategy focused on multi-channel EsoGuard commercialization NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (“PAVmed” or the “Company”), a hi...

Company conference call and webcast at 4:30 PM EDT NEW YORK, May 03, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announ...

When #institutionalinvestors make decisions to buy and sell #stocks they normally want to keep it quiet.  However, if we pay close attention we can see what is going on, and make good decisions.. The Pavmed Inc. Common Stock (NASDAQ: PAVM) report below can help you understa...

NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (“PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that its major subsidiary Lucid Diagnostics Inc. (“Lucid” or the &...

NEW YORK, April 27, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced the appointment of prominent UK-based global ...

Investors often shrug off the impact of stimulus, but when fabricated demand comes into the stock market everything is affected, even Pavmed Inc. Common Stock (NASDAQ: PAVM) and other stocks that might not be direct beneficiaries.  They say, a rising tide lifts all boats, and multi...

Are These The Best Penny Stocks To Buy Right Now? Penny stocks are an interesting type of investment choice. I say this because, on the one hand, you’re buying into mostly start-up phase companies. So the potential for long-term gains would theoretically be higher. But on the oth...

NEW YORK, April 15, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a commercial-stage, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Office...

Gainers: Mackinac Financial (MFNC) +56%.NovoCure (NVCR) +42%.vTv Therapeutics (VTVT) +42%.Digimarc (DMRC) +20%.PLBY Group (PLBY) +20%.Ballantyne Strong (BTN) +20%.Birks Group (BGI) +18%.Zai Lab (ZLAB) +16%.B. Riley Financial (RILY) +15%.Nam Tai Property (NTP) +14%.Losers: Brook...

PAVmed Inc. (NASDAQ:PAVM) traded at a new 52-week high today of $5.94. So far today approximately 2.4 million shares have been exchanged, as compared to an average 30-day volume of 5 million shares. PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technol...